Bridge City Capital, LLC Emergent Bio Solutions Inc. Transaction History

Bridge City Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$27.42 - $43.63 $1.09 Million - $1.74 Million	-39,835 Closed	0 $0
Q1 2022 May 18, 2022	SELL	$36.48 - $52.22 $621,400 - $889,515	-17,034 Reduced 29.95%	39,835 $1.64 Million
Q4 2021 Jan 20, 2022	BUY	$33.11 - $55.01 $629,983 - $1.05 Million	19,027 Added 50.28%	56,869 $2.47 Million
Q3 2021 Nov 10, 2021	BUY	$50.07 - $66.05 $72,701 - $95,904	1,452 Added 3.99%	37,842 $1.9 Million
Q2 2021 Aug 11, 2021	SELL	$56.61 - $80.46 $69,913 - $99,368	-1,235 Reduced 3.28%	36,390 $2.29 Million
Q1 2021 Apr 28, 2021	BUY	$86.23 - $125.19 $3.24 Million - $4.71 Million	37,625 New	37,625 $3.5 Million

172

36.8M

336K

203K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $384M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Bridge City Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridge City Capital, LLC with notifications on news.